Logo image
Could chimeric antigen receptor-T cell treatment of atherosclerosis in mice translate to a human therapy?
Letter/Communication   Open access   Peer reviewed

Could chimeric antigen receptor-T cell treatment of atherosclerosis in mice translate to a human therapy?

Steven Gieseg, Barry Hock, Martins Ogugofor and Sally McCormick
Annals of translational medicine, Vol.14(4), 55
31/08/2026
Handle:
https://hdl.handle.net/10523/52418

Abstract

commentary atherosclerosis emerging treatments
Editorial commentary on Schwab RD, Degaramo D, Hong SJ, et al. Chimeric antigen receptor regulatory T cells targeted against oxidized low-density lipoprotein reduce atherosclerotic plaque development. Circulation 2026,153:319-37, https://doi.org/10.1161/CIRCULATIONAHA.125.073987.
pdf
atm-14-04-55141.88 kBDownloadView
Published (Version of record) Open Access CC BY-NC-ND V4.0
url
https://doi.org/10.21037/atm-2026-0132View
Published (Version of record) Open CC BY-NC-ND V4.0

Metrics

1 Record Views

Details

Logo image